Skip to main content
. 2019 Dec 13;10:1433. doi: 10.3389/fphar.2019.01433

Figure 4.

Figure 4

Salidroside improves neurobehavioral impairment after MCAO. Rats that were treated with 80, 40, and 20 mg/kg salidroside or saline water prior to MCAO exhibited significant change in the mNSS test (A), balance beam test (B), and foot fault test (C). Data are expressed as the mean ± SEM, n = 7. **p < 0.01, ***p < 0.001 compared to the sham group; # p < 0.05, ## p < 0.01, ### p < 0.001 compared to the MCAO group. MCAO middle cerebral artery occlusion, mNSS modified neurological severity score, SEM standard error of the mean.